Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

Will weight loss drugs kill the fast food business?

Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite counts’

The Guardian - UK

Ozempic and Wegovy Show Lower Risk of Suicidal Thoughts

Hold onto your hats, folks, because there's some fascinating news in the world of diabetes and obesity drugs! A recent federal study found that people taki...

Top News

People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds

A new federal study finds that people taking popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Novo Nordisk, IBD Stock Of The Day, Flashes Buy Signal Amid The Weight-Loss Craze

Novo Nordisk stock is Friday's IBD Stock Of The Day. Shares are in a buy zone after the firm inked deals in the weight-loss drugs space.

Investors Business Daily

Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review

The S&P 500 snapped a nine-week win streak, but tried to find support. Tesla, Apple and Mobileye were key losers.

Investors Business Daily

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024

Biotech stocks are heating up as multibillion-dollar deals pile up and new modalities like CRISPR gene-editing hit prime time.

Investors Business Daily

Dow Jones Futures Fall Amid Jobs Report As Fed Doubts Grow; Spot Bitcoin ETFs Loom

The major indexes held up Thursday with bullish action from many leading stocks. The December jobs report and spot Bitcoin ETF approvals loom.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly Stock: Buy or Sell?

Eli Lilly's diversified portfolio and high demand for its weight-loss drugs have pushed it to the top of Wall Street's list of top pharma stocks for 2024. Is now the time to buy?

Barchart

Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity

Novo Nordisk inked a pair of deals Thursday to bolster its weight-loss drugs franchise, and sent shares of Omega into the stratosphere.

Investors Business Daily

Insulin Now Available for $35 a Month for Many Americans

Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month.

Kiplinger

The Guardian view on anti-obesity drugs: treating a disease that modernity made

Editorial: Weight-loss drugs reveal that obesity is not a deep-seated aspect of character but something more contingent

The Guardian - UK

FDA says watch out for fake Ozempic, a diabetes drug used by many for weight loss

Thousands of fake units of the drug have been seized by the FDA, which is working alongside the manufacturer to test the counterfeit products for safety concerns.

WEKU

FDA warns that counterfeit Ozempic is flooding US supply chain

Officials have seized thousands of counterfeit units

The Independent UK

FDA Seizes Thousands of Counterfeit Ozempic Shots for Diabetes

Counterfeit Ozempic diabetes drug seized by FDA, prompting concerns over identity, quality, and safety. Report suspect packages to FDA hotline.

Top News

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall As Nike Dives; Apple Leads Six Stocks To Watch With Inflation Data Due

The major indexes rebounded Thursday, with the Fed's favorite inflation data due. Apple and Carnival lead stocks to watch.

Cycling Weekly

'I had to set two alarms at night to check my glucose to make sure I wouldn’t die': meet the revolutionary who won't stop until cycling is safer

The UCI banned his technology from races, yet Supersapiens boss Phil Southerland tells Chris Marshall-Bell he is still dead set on changing the sport in the most profound way for decades

The Independent UK

Weight loss from Lilly’s Zepbound drug reversed after stopping treatment, according to study

‘They gain back about half the weight they had originally lost over a one-year period of time,’ professor says

Investors Business Daily

Eli Lilly Stock Skids On A Key New Finding For Its Obesity Drug, Zepbound

Eli Lilly stock skidded Monday after a new study showed patients who stopped taking its weight-loss drug slowly regained weight over a year.

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

Investors Business Daily

Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives

Novo Nordisk stock skidded Tuesday after Eli Lilly's weight-loss drug outperformed Novo's rival medication in a first-of-its-kind study.

Fortune

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

Weight-loss drug Wegovy faces high demand, limited supply, and tricky health care systems to navigate.

Investors Business Daily

Dow Jones Futures Fall: Market Rally Looks Great, But Beware This; 8 Stocks Near Buy Points

The market rally continues its strong November run, but a key fear gauge raises some concerns. Weight-loss drug giant Novo Nordisk broke out Friday, leading stocks to watch.

Barchart

3 Buy-Rated Healthcare Dividend Stocks for Income Investors

Looking for analysts' favorite stock picks in a traditionally defensive sector, with solid dividend payments to help boost your returns? Here's a look at three stocks for income investors to consider at current levels.

Investors Business Daily

Eli Lilly Stock Nears Another Record As Drugmaker Enters The Weight-Loss Arena

Eli Lilly stock is Monday's IBD Stock Of The Day. Shares are forming a new flat base after the FDA approved Lilly's new weight-loss drug.

The Guardian - UK

Revealed: obesity jab maker discussed targeting benefit claimants with UK government

Drug firm Novo Nordisk proposed singling out those most likely to return to work with its weight-loss injection

1 … 17 18 19 20

People

Lars Fruergaard Jørgensen

17 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.